Comment: POLO III trial for metastatic pancreatic cancer

CheckMate-142: Updated data from MSI high metastatic colon cancer patients

Comment: Laparoscopic versus open resection for colorectal liver metastases

Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer

VOLFI trial final results: mFOLFOXIRI and panitumumab versus FOLFOXIRI in ECOG 0-1 and primarily non-resectable mCRC patients

Highlights from ASCO 2019

Long-term survival after laparoscopic versus open resection for colorectal liver metastases

No difference in survival between laparoscopic surgery and open surgery in colorectal cancer patients with liver metastases

Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer with focus on intermediate IMDC-risk population

Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitinib in aRCC

KEYNOTE-062 study: Pembrolizumab as treatment for advanced gastroesophageal junction and gastric cancers

Pembrolizumab comparable to chemotherapy for patients with advanced gastric or gastroesophageal junction cancers